MedPath

JARDIANCE

JARDIANCE

Approved
DIN Number

02443937

Drug Class

Human

Market Date

Aug 11, 2015

Company
HC

boehringer ingelheim (canada) ltd ltee

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02443937
AIG Number0157150001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BK03 EMPAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

EMPAGLIFLOZINActive
Strength: 10 MG
Monograph: EMPAGLIFLOZIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.